The most common strategy for prolonging the benefits of ketamine in treatment-resistant depression is the readministration of ketamine, despite a lack of evidence regarding the long-term safety, efficacy, and feasibility of this practice.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• ketamine concept
• treatment-resistant depression concept